Differentiating Virtual Education to Optimize Outcomes
Study Authors: Erik D. Axene, MD, FACEP, MA and David V. Axene, FSA, FCA, CERA, MAAA Abstract: Prehospital [...]
Study Authors: Erik D. Axene, MD, FACEP, MA and David V. Axene, FSA, FCA, CERA, MAAA Abstract: Prehospital [...]
In the ever-evolving landscape of healthcare, the terms "value-based reimbursement" and "value-based care" (VBC) have become buzzwords that [...]
As we try to identify key causes of high US healthcare costs, the topic of variation, specifically [...]
Unlike insurers whose plans must comply with strict metal tier and essential health benefit requirements, self-funded groups [...]
A former colleague came across an article I wrote last year, 'My Recent Experience with Kaiser Health System' [...]
To achieve savings benefits from the coming wave of biosimilars, biosimilars must be adopted by prescribers, members, [...]
As with many things in life, change is challenging, often undetected when it starts, many times mislabeled [...]
Once the first Humira biosimilar, Amjevita, launched in the United States in January, payers needed to begin [...]
Health insurers are required to hold minimum levels of surplus each year. However, the exact amount a health [...]
For a healthcare system to run efficiently there is a balance that needs to be found where there [...]